Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
Syra Health (NASDAQ: SYRA) has secured two significant contracts: a new healthcare workforce contract with the Washington D.C. government valued at up to $1 million, and a $1.2 million extension to an existing contract with Indiana's NeuroDiagnostic Institute, bringing its total value to $18.7 million.
The D.C. contract, awarded on behalf of the Office of the State Superintendent of Education, involves deploying registered nurses, licensed practical nurses, and certified nursing assistants to provide healthcare services to students. This one-year agreement includes extension options and requires developing individualized service plans for students.
The expanded Indiana contract continues Syra Health's support in providing healthcare professionals to evaluate and treat patients with complex neuropsychiatric illnesses at the NeuroDiagnostic Institute. This marks Syra Health's fourth contract with the D.C. government, building on their partnership with the NeuroDiagnostic Institute that began in 2021.
Syra Health (NASDAQ: SYRA) ha ottenuto due contratti significativi: un nuovo contratto per la forza lavoro nel settore sanitario con il governo di Washington D.C. del valore massimo di $1 milione, e un'estensione di $1,2 milioni a un contratto esistente con l'Istituto Neurodiagnostico dell'Indiana, portando il valore totale a $18,7 milioni.
Il contratto con D.C., assegnato per conto dell'Ufficio del Sovrintendente Statale per l'Istruzione, prevede il dispiegamento di infermieri registrati, infermieri pratici autorizzati e assistenti infermieristici certificati per fornire servizi sanitari agli studenti. Questo accordo di un anno include opzioni di estensione e richiede lo sviluppo di piani di servizio individualizzati per gli studenti.
Il contratto espanso dell'Indiana continua a supportare Syra Health nel fornire professionisti sanitari per valutare e trattare pazienti con malattie neuropsichiatriche complesse presso l'Istituto Neurodiagnostico. Questo segna il quarto contratto di Syra Health con il governo di D.C., ampliando la loro collaborazione con l'Istituto Neurodiagnostico iniziata nel 2021.
Syra Health (NASDAQ: SYRA) ha conseguido dos contratos significativos: un nuevo contrato de fuerza laboral en salud con el gobierno de Washington D.C. valorado en hasta $1 mill贸n, y una extensi贸n de $1.2 millones a un contrato existente con el Instituto Neurodiagn贸stico de Indiana, elevando su valor total a $18.7 millones.
El contrato de D.C., adjudicado en nombre de la Oficina del Superintendente Estatal de Educaci贸n, implica el despliegue de enfermeras registradas, enfermeras pr谩cticas con licencia y asistentes de enfermer铆a certificados para brindar servicios de salud a los estudiantes. Este acuerdo de un a帽o incluye opciones de extensi贸n y requiere el desarrollo de planes de servicio individualizados para los estudiantes.
El contrato ampliado de Indiana contin煤a el apoyo de Syra Health en la provisi贸n de profesionales de salud para evaluar y tratar a pacientes con enfermedades neuropsiqui谩tricas complejas en el Instituto Neurodiagn贸stico. Este es el cuarto contrato de Syra Health con el gobierno de D.C., fortaleciendo su asociaci贸n con el Instituto Neurodiagn贸stico que comenz贸 en 2021.
Syra Health (NASDAQ: SYRA)電� 霊� 臧滌潣 欷戩殧頃� 瓿勳暯鞚� 觳搓舶頄堨姷雼堧嫟. 頃橂倶電� 鞗岇嫳韯� D.C. 鞝曤秬鞕� 斓滊寑 100毵� 雼煬 攴滊鞚� 靸堧鞖� 鞚橂 鞚鸽牓 瓿勳暯鞚措┌, 雼るジ 頃橂倶電� 鞚鸽敂鞎犽倶鞚� 鞁犼步歆勲嫧 鞐瓣惮靻岇檧 旮办〈 瓿勳暯鞚� 120毵� 雼煬搿� 鞐办灔頃橃棳 齑� 瓿勳暯 攴滊毳� 1870毵� 雼煬搿� 電橂牳鞀惦媹雼�.
D.C. 瓿勳暯鞚� 欤� 甑愳湣臧� 靷鞁れ潉 雽�鞁犿暣 靾橃棳霅� 瓴冹溂搿�, 霌彪霅� 臧勴樃靷�, 氅错棃臧� 鞛堧姅 鞁れ姷 臧勴樃靷� 氚� 鞚胳霅� 臧勴樃 氤挫“鞚胳潉 氚办箻頃橃棳 頃欖儩霌れ棎瓴� 鞚橂 靹滊箘鞀るゼ 鞝滉车頃橂姅 雮挫毄鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟. 鞚� 1雲� 瓿勳暯鞚� 鞐办灔 鞓奠厴鞚� 韽暔霅橃柎 鞛堨溂氅� 頃欖儩霌れ潉 鞙勴暅 臧滊硠 靹滊箘鞀� 瓿勴殟鞚� 臧滊皽頃橂姅 瓴冹潉 鞖旉惮頃╇媹雼�.
頇曥灔霅� 鞚鸽敂鞎犽倶 瓿勳暯鞚� 鞁犼步歆勲嫧 鞐瓣惮靻岇棎靹� 氤奠灐頃� 鞁犼步鞝曥嫚 歆堩櫂鞚� 臧�歆� 頇橃瀽毳� 韽夑皜頃橁碃 旃橂頃橁赴 鞙勴暣 鞚橂 鞝勲臧�毳� 鞝滉车頃橂姅 Syra Health鞚� 歆�鞗愳潉 瓿勳啀頃╇媹雼�. 鞚措姅 Syra Health鞚� D.C. 鞝曤秬鞕�鞚� 雱� 氩堨Ц 瓿勳暯鞙茧, 2021雲勳棎 鞁滌瀾霅� 鞁犼步歆勲嫧 鞐瓣惮靻岇檧鞚� 韺岉姼雱堨嫮鞚� 氚旐儠鞙茧 頃橁碃 鞛堨姷雼堧嫟.
Syra Health (NASDAQ: SYRA) a obtenu deux contrats importants : un nouveau contrat pour la main-d'艙uvre en sant茅 avec le gouvernement de Washington D.C. d'une valeur pouvant atteindre 1 million de dollars, et une extension de 1,2 million de dollars 脿 un contrat existant avec l'Institut Neurodiagnostique de l'Indiana, portant la valeur totale 脿 18,7 millions de dollars.
Le contrat avec D.C., attribu茅 au nom du Bureau du Superintendant d'脡tat 脿 l'脡ducation, implique le d茅ploiement d'infirmi猫res dipl么m茅es, d'infirmi猫res pratiques agr茅茅es et d'assistants de soins infirmiers certifi茅s pour fournir des services de sant茅 aux 茅tudiants. Cet accord d'un an comprend des options d'extension et n茅cessite l'茅laboration de plans de services individualis茅s pour les 茅tudiants.
Le contrat 茅largi de l'Indiana continue de soutenir Syra Health dans la fourniture de professionnels de sant茅 pour 茅valuer et traiter des patients souffrant de maladies neuropsychiatriques complexes 脿 l'Institut Neurodiagnostique. Cela repr茅sente le quatri猫me contrat de Syra Health avec le gouvernement de D.C., renfor莽ant leur partenariat avec l'Institut Neurodiagnostique qui a commenc茅 en 2021.
Syra Health (NASDAQ: SYRA) hat zwei bedeutende Vertr盲ge gesichert: einen neuen Vertrag f眉r die Gesundheitsfachkr盲fte mit der Regierung von Washington D.C. im Wert von bis zu 1 Million Dollar und eine 1,2 Millionen Dollar Erweiterung eines bestehenden Vertrags mit dem Neurodiagnostischen Institut von Indiana, was den Gesamtwert auf 18,7 Millionen Dollar erh枚ht.
Der D.C.-Vertrag, der im Auftrag des B眉ros des staatlichen Schulaufsichtsbeamten vergeben wurde, umfasst die Bereitstellung von registrierten Krankenschwestern, lizenzierten praktischen Krankenschwestern und zertifizierten Pflegeassistenten, um Gesundheitsdienste f眉r Sch眉ler bereitzustellen. Diese einj盲hrige Vereinbarung umfasst Verl盲ngerungsoptionen und erfordert die Entwicklung individueller Dienstleistungspl盲ne f眉r die Sch眉ler.
Der erweiterte Vertrag von Indiana setzt die Unterst眉tzung von Syra Health bei der Bereitstellung medizinischer Fachkr盲fte zur Bewertung und Behandlung von Patienten mit komplexen neuropsychiatrischen Erkrankungen am Neurodiagnostischen Institut fort. Dies ist der vierte Vertrag von Syra Health mit der Regierung von D.C. und baut auf ihrer Partnerschaft mit dem Neurodiagnostischen Institut auf, die 2021 begann.
- Secured new contract worth up to $1M with Washington D.C. government
- Existing contract with Indiana increased by $1.2M to total $18.7M
- Fourth contract secured with Washington D.C. government, showing strong client relationship
- Contract includes potential extensions, indicating growth opportunities
- None.
Insights
The dual contract announcements represent a total value increase of $2.2 million for Syra Health, with significant strategic implications. The new
The D.C. contract's focus on student healthcare services aligns with growing demand for school-based health services, a market segment experiencing rapid expansion due to increased awareness of student health needs. The contract's extension options provide recurring revenue potential and stability. The Indiana contract extension, bringing the total to
These developments indicate Syra Health's successful execution of a dual-market strategy: expanding geographical presence while deepening existing relationships. The company's ability to secure multiple contracts with the D.C. government suggests strong competitive positioning in the public sector healthcare services market.
The contract wins are particularly significant given Syra Health's current market capitalization. The
The nature of these contracts - government-backed healthcare staffing services - provides revenue visibility and reduced collection risk. The D.C. contract's structure, with extension options, creates potential for long-term revenue streams. The expansion of the Indiana contract from an existing relationship demonstrates the company's ability to grow accounts, a important factor for sustainable business growth.
Syra Health will deploy registered nurses, licensed practical nurses, and certified nursing assistants to deliver healthcare services to students as part of
In addition to this new contract, Syra Health continues to expand its support for the Indiana Family and Social Services Administration's NeuroDiagnostic Institute. Syra Health provides healthcare professionals to the Institute to evaluate and treat patients with complex neuropsychiatric illnesses.
"These contracts highlight our deep commitment to driving better health outcomes," said Dr. Deepika Vuppalanchi, CEO of Syra Health. "By providing tailored services that alleviate staffing shortages and ensure continuity of care, we are not only addressing immediate healthcare needs but also supporting long-term solutions. This marks our fourth contract with the
About Syra Health
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world.
Forward-Looking Statements聽
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For Investor or Media Inquiries:
Christine Drury
IR/PR
Syra Health
463-345-5180
christined@syrahealth.com
View original content to download multimedia:
SOURCE Syra Health
FAQ
What is the value of Syra Health's (SYRA) new Washington D.C. contract in 2025?
How much was the contract extension with Indiana's NeuroDiagnostic Institute worth for SYRA?
What services will Syra Health (SYRA) provide under the Washington D.C. contract?
How many contracts has SYRA secured with the Washington D.C. government?
When did Syra Health (SYRA) begin its partnership with Indiana's NeuroDiagnostic Institute?
